Titlebook: Management of Breast Cancer in Older Women; Malcolm Reed,Riccardo A. Audisio Book 2019Latest edition Springer Nature Switzerland AG 2019 T

和善

书目名称Management of Breast Cancer in Older Women影响因子(影响力)




书目名称Management of Breast Cancer in Older Women影响因子(影响力)学科排名




书目名称Management of Breast Cancer in Older Women网络公开度




书目名称Management of Breast Cancer in Older Women网络公开度学科排名




书目名称Management of Breast Cancer in Older Women被引频次




书目名称Management of Breast Cancer in Older Women被引频次学科排名




书目名称Management of Breast Cancer in Older Women年度引用




书目名称Management of Breast Cancer in Older Women年度引用学科排名




书目名称Management of Breast Cancer in Older Women读者反馈




书目名称Management of Breast Cancer in Older Women读者反馈学科排名

offense

Adjuvant Endocrine Therapy,n and sequencing of ET in post-menopausal women, which can assist clinicians in their recommendations to elderly patients. This chapter will summarise the findings of these seminal trials, and their applicability to the elderly subpopulation will be discussed.

吞噬

,Nurses’ Role in Care of Older Women with Breast Cancer,e including, but not limited to, providing clinical care, to psychosocial support, to helping patients navigate the system. This chapter will highlight the importance of nurses in providing care for older women with breast cancer through their trajectory of care.

船员

膝盖

Book 2019Latest editionatients with breast cancer. It presents the most up-to-date research and clinical practice from  leading specialists across a range of fields that come into contact with older breast cancer patients.. .With new chapters on nursing and clinical trials in older women, as well as patient perspectives a

禁止

补充

Heresy

Primary Endocrine Therapy,is setting. Primary endocrine therapy is well tolerated and may avoid unnecessary morbidity for some women if selected appropriately. At present there are no evidence based selection guidelines but it is hoped these will be published soon once the Age Gap trial reports.

Delude

CRASS

Medical Management of Advanced Disease,s and agents is dependent on individual patient characteristics, preferences, and drug availability. Targeted treatments are used more and more, and also in older persons they can provide major clinical benefit with acceptable safety profile.